Long-term Outcomes and Role of Chemotherapy in Adults With Newly Diagnosed Medulloblastoma
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 37 (1) , 1-7
Abstract
Objective: To assess the survival and role of adjuvant chemotherapy in adult medulloblastoma. Methods: We reviewed outcomes of 66 patients (aged 18 y or more; median age, 33 y) with medulloblastoma. Forty-four (67%) patients had M0 disease, 9 had M1-M4, and 13 had MX. Thirty-one patients each for whom risk stratification was available were classified as high risk or standard risk. Fifty-six patients had histologic results: classic histology was the most common (n=46 [84%]), followed by desmoplastic (n=9), and large cell/anaplastic (n=1). Overall survival (OS) and progression-free survival (PFS) were estimated with Kaplan-Meier curves and log-rank tests. Cox regression analysis was used to compare recurrences. Results: Median follow-up was 6.7 years. The estimated 5-year OS and PFS were 74% and 59%, respectively. High-risk versus standard-risk classification was associated with worse OS (61% vs. 86%; P=0.03) and recurrence (hazard ratio, 2.56; P=0.05) and a trend for worse PFS (49% vs. 69%; P=0.13). Gross total resection was associated with improved OS (P=0.03) and a trend toward improved PFS (P=0.09). No chemotherapy benefit could be demonstrated for the group as a whole. For high-risk patients with classic histology (n=25), chemotherapy was associated with a trend for improvement in 5-year PFS from 36% to 71% (P=0.10) and in 5-year OS from 49% to 100% (P=0.08). Conclusions: In adult patients with medulloblastoma, the extent of resection and risk classification predicts the outcome. These results suggest a chemotherapy benefit for high-risk patients with classic histology.Keywords
This publication has 31 references indexed in Scilit:
- Le médulloblastome de l’enfant et de l’adulte : quelle différence ?Cancer/Radiothérapie, 2009
- Survival and prognostic factors in a series of adults with medulloblastomasJournal of Neurosurgery, 2009
- Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET)Critical Reviews in Oncology/Hematology, 2009
- Survival of patients with adult medulloblastomaCancer, 2008
- Long‐term results of a prospective study on the treatment of medulloblastoma in adultsCancer, 2007
- Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJournal of Clinical Oncology, 2006
- Adult Medulloblastoma: Prognostic Factors and Patterns of RelapseNeurosurgery, 2000
- Medulloblastoma in adults: clinical characteristics and treatmentCancer Treatment Reviews, 1999
- Medulloblastoma in adultsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Survival results in adult patients treated for medulloblastomaCancer, 1992